-
IN VIVO BEHAVIOR OF I-FIBRINOGEN.
J Clin Invest. 1963 Mar;42(3):346-61
PMID: 16695897
-
ANTIGEN-ANTIBODY CROSSED ELECTROPHORESIS.
Anal Biochem. 1965 Feb;10:358-61
PMID: 14302464
-
THE ROLE OF SERUM COMPLEMENT IN CHEMOTAXIS OF LEUKOCYTES IN VITRO.
J Exp Med. 1965 Aug 1;122:327-46
PMID: 14316948
-
ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.
J Exp Med. 1965 Aug 1;122:277-98
PMID: 14316946
-
IMMUNE BACTERICIDAL ACTIVITY OF COMPLEMENT. SEPARATION AND DESCRIPTION OF INTERMEDIATE STEPS.
J Immunol. 1964 Aug;93:319-30
PMID: 14202263
-
The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes.
J Exp Med. 1962 Mar 1;115:453-66
PMID: 13872176
-
Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway.
J Exp Med. 1976 Oct 1;144(4):970-84
PMID: 62019
-
The chromosomal order of genes controlling the major histocompatibility complex, properdin factor B, and deficiency of the second component of complement.
J Clin Invest. 1976 Nov;58(5):1240-8
PMID: 993342
-
Chromosome 6: linkage of the eighth component of complement (C8) to the histocompatibility region (HLA).
Cytogenet Cell Genet. 1976;16(1-5):331-4
PMID: 975903
-
Inherited deficiency of the second component of complement. Rheumatic disease associations.
J Clin Invest. 1976 Oct;58(4):853-61
PMID: 965492
-
Generation of chemotactic factors in guinea pig serum via activation of the classical and alternate complement pathways.
Clin Immunol Immunopathol. 1973 Apr;1(3):414-26
PMID: 4201402
-
The C3-activator system: an alternate pathway of complement activation.
J Exp Med. 1971 Sep 1;134(3 Pt 2):90s-108s
PMID: 4105810
-
Immune lytic transformation: a state of irreversible damage generated as a result of the reaction of the eighth component in the guinea pig complement system.
J Immunol. 1968 Jan;100(1):46-54
PMID: 4169697
-
Precipitin reactions of the C1q component of complement with aggregated gamma-globulin and immune complexes in gel diffusion.
Immunology. 1970 Dec;19(6):909-19
PMID: 4098878
-
Neutralization of sensitized virus by purified components of complement.
Proc Natl Acad Sci U S A. 1970 Mar;65(3):528-35
PMID: 4315612
-
A new one-step method for the functional assay of the fourth component (C4) of human and guinea pig complement.
J Immunol. 1974 Aug;113(2):574-83
PMID: 4210883
-
Editorial: Systemic lupus erythematosus and type C RNA viruses.
N Engl J Med. 1976 Aug 26;295(9):501-2
PMID: 59901
-
Human heat labile opsonins: evidence for their mediation via the alternate pathway of complement activation.
J Immunol. 1972 Jul;109(1):26-31
PMID: 4624675
-
Genetic abnormalities of the complement system of man associated with disease.
Transplant Proc. 1974 Mar;6(1):59-65
PMID: 4593655
-
Genetic aspects of diseases of complement: an explosion.
Am J Med. 1975 Jan;58(1):105-11
PMID: 46701
-
The role of the histocompatibility-2-linked Ss-Slp region in the control of mouse complement.
Proc Natl Acad Sci U S A. 1973 Mar;70(3):863-4
PMID: 4514997
-
Linkage of HL-A and GBG.
Vox Sang. 1974;27(4):382-4
PMID: 4414487
-
Evidence for linkage between HL-A histocompatibility genes and those involved in the synthesis of the second component of complement.
J Exp Med. 1974 Oct 1;140(4):1108-11
PMID: 4427089
-
Immunochemical quantitation of antigens by single radial immunodiffusion.
Immunochemistry. 1965 Sep;2(3):235-54
PMID: 4956917
-
The serum bactericidal reaction. 3. Antibody and complement requirements for killing a rough Escherichia coli.
J Immunol. 1969 Jun;102(6):1379-87
PMID: 4891549
-
Human deficiency of the eighth component of complement. The requirement of C8 for serum Neisseria gonorrhoeae bactericidal activity.
J Clin Invest. 1976 Feb;57(2):283-90
PMID: 815273
-
Hereditary deficiency of the seventh component of complement.
J Clin Invest. 1975 Oct;56(4):905-13
PMID: 1099121
-
A new complement function: solubilization of antigen-antibody aggregates.
Proc Natl Acad Sci U S A. 1975 Feb;72(2):418-22
PMID: 1054824
-
Hereditary deficiency of the fifth component of complement in man. I. Clinical, immunochemical, and family studies.
J Clin Invest. 1976 Jun;57(6):1626-34
PMID: 932197
-
The membrane attack mechanism of complement: the three polypeptide chain structure of the eigth component (C8).
J Exp Med. 1976 May 1;143(5):1131-9
PMID: 1262784
-
Studies on the mechanism of solubilization of immune precipitates by serum.
J Exp Med. 1976 Mar 1;143(3):615-30
PMID: 1249522
-
Genetic linkage between serum levels of the third component of complement and the H-2 complex.
J Exp Med. 1975 Feb 1;141(2):513-7
PMID: 1113067
-
Inherited complement deficiencies and systemic lupus erythematosus: an immunogenetic puzzle.
Ann Intern Med. 1975 Mar;82(3):420-1
PMID: 1115480
-
Hereditary C2 deficiency: Genetic studies and association with the HL-A system.
J Exp Med. 1975 Jun 1;141(6):1464-9
PMID: 1127385
-
Biological activity of complement in vivo. Role of C5 in the accumulation of polymorphonuclear leukocytes in inflammatory exudates.
J Exp Med. 1971 Nov 1;134(5):1131-43
PMID: 5112201
-
Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test.
Transplantation. 1968 Nov;6(8):913-27
PMID: 5696820
-
Complement dependent immune phagocytosis. I. Requirements for C'1, C'4, C'2, C'3.
Exp Cell Res. 1968 Jul;51(1):45-67
PMID: 5661952
-
Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum.
Immunochemistry. 1966 Mar;3(2):111-35
PMID: 5960883
-
Serum heat-labile opsonins in systemic lupus erythematosus.
J Clin Invest. 1974 Feb;53(2):343-53
PMID: 11344546